Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Industry | 2 |
| Pharmacy | 2 |
| Risk | 2 |
| Cost Effectiveness | 1 |
| Drug Therapy | 1 |
| Equipment | 1 |
| Evidence | 1 |
| Financial Support | 1 |
| Global Approach | 1 |
| Medical Education | 1 |
| Medical Services | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkWolfrey, Jeff; Brown, Steven R.; Ebell, Mark H.; Geng, Jamie – Journal of Continuing Education in the Health Professions, 2012
Concerns about the influence of the pharmaceutical and medical device industries on continuing medical education (CME) have been voiced frequently over the past decade. Reliance on industry funding increases the potential for bias. Industry-supported CME often emphasizes conditions that can be treated with newer drugs or devices rather than those…
Descriptors: Evidence, Public Health, Medical Education, Industry
Scott, J. Blake – Quarterly Journal of Speech, 2006
The pharmaceutical industry's response to the threat of bioterrorism following 9-11 invoked the rhetorical notion of kairos as an urgent and ongoing opportunity not only to protect the nation but also to improve the industry's reputation and fortify its political power. Yet the notion of kairos as seizing an advantage--grounded in modernist…
Descriptors: Pharmacy, Industry, Terrorism, Responses
